| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/29/2004 | WO2004009759A2 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 01/29/2004 | WO2004009758A2 Embryonic stem cell markers and uses thereof |
| 01/29/2004 | WO2004009757A1 Cell culture apparatus and method of cell culture |
| 01/29/2004 | WO2004009541A2 Antisense modulation of endothelial lipase expression |
| 01/29/2004 | WO2004009237A2 Sperm cell process system |
| 01/29/2004 | WO2004009132A1 Selected cell delivery for heart failure |
| 01/29/2004 | WO2003066663A3 Peptides for recognition and targeting of glial cell tumors |
| 01/29/2004 | WO2003059932A3 Methods of inducing or enhancing connective tissue repair |
| 01/29/2004 | WO2003048184A3 Flavivirus ns1 subunit vaccine |
| 01/29/2004 | WO2003044186A3 Novel gene cluster of pederin biosynthesis genes |
| 01/29/2004 | WO2003039489A3 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof |
| 01/29/2004 | WO2003039471A3 Catalytic antibodies raised against sarin and process for the preparation thereof |
| 01/29/2004 | WO2003018766A3 Self-processing plants and plant parts |
| 01/29/2004 | WO2003016537A3 Method for repairing a mutant rna from a dna with genetic defects and for the programmed death of tumour cells by rna trans-splicing as well as a method for identifying naturally trans-spliced cellular rna |
| 01/29/2004 | WO2003008451A3 Modification of human variable domains |
| 01/29/2004 | WO2003002137A3 Trp1, mct, or ftz-f1 homologous proteins involved in the regulation of energy homeostasis |
| 01/29/2004 | WO2003000199A3 Ilt3 and ilt4-related compositions and methods |
| 01/29/2004 | WO2002099060A3 Dgks as modifiers of the p53 pathway and methods of use |
| 01/29/2004 | WO2002078631A3 Improved conditionally replicating vectors for inhibiting viral infections |
| 01/29/2004 | WO2002077036A3 Recombinant production of polyanionic polymers, and uses thereof |
| 01/29/2004 | WO2002072794A3 Immunoglobulin superfamily proteins |
| 01/29/2004 | WO2002070737A3 Compositions and methods relating to osteoarthritis |
| 01/29/2004 | WO2002066615A9 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 01/29/2004 | US20040019935 Gene of aluminum-activated malate transporter of a plant and a protein encoded by the gene |
| 01/29/2004 | US20040019934 Root-specific conifer gene promoter and its use |
| 01/29/2004 | US20040019919 Calsyntenin-1-3 proteins, predominantly expressed in the nervous system , useful for the screening and for the preparation of a medicament for the treatment of nervous system disorders, most preferably brain |
| 01/29/2004 | US20040019915 Nucleic acid and corresponding protein entitled 213P1F11 useful in treatment and detection of cancer |
| 01/29/2004 | US20040019390 Methods and compositions for allogeneic transplantation |
| 01/29/2004 | US20040019103 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof |
| 01/29/2004 | US20040019009 A compound 8 to 50 nucleobases in length targeted to a nucleic acid molecule, specifically hybridizes with such nucleic acid, encoding IL-1 receptor-associated kinase-4; useful for treating cancer, infection and inflammation |
| 01/29/2004 | US20040019002 Gene repair involving the induction of double-stranded DNA cleavage at a chromosomal target site |
| 01/29/2004 | US20040018999 Methods and compositions for RNA interference |
| 01/29/2004 | US20040018977 Semaphorin-like proteins and methods of using same |
| 01/29/2004 | US20040018969 Genetic engineering; central nervous system disorders |
| 01/29/2004 | US20040018627 High-efficiency AAV helper functions |
| 01/29/2004 | US20040018626 Replacement of immunoglobulin in endogenous cells; forming embryos stem cell |
| 01/29/2004 | US20040018624 Compositions and methods for making mutations in cell lines and animals |
| 01/29/2004 | US20040018623 From pancreas; three-dimensional culture product; immobilization; diabetic therapy |
| 01/29/2004 | US20040018622 Therapy for skin disorders; genetic defects |
| 01/29/2004 | US20040018621 Culture product; gene therapy for liver disorders |
| 01/29/2004 | US20040018620 Hepatocyte precursor cell lines |
| 01/29/2004 | US20040018619 Central nervous system disorders; psychological disorders; therapy for brain tumors |
| 01/29/2004 | US20040018618 Genetic engineering; hybrid proteins; gene expression; human gene therapy |
| 01/29/2004 | US20040018617 Culture product of animal cells; mammal embryo stem cells |
| 01/29/2004 | US20040018602 Adjust tocopherol in plant cells; nucleic acid construct |
| 01/29/2004 | US20040018600 Microbial conversion of glucose to para-hydroxystyrene |
| 01/29/2004 | US20040018594 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 01/29/2004 | US20040018569 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection |
| 01/29/2004 | US20040018547 Ion channel receptor and uses thereof |
| 01/29/2004 | US20040018545 Nucleic acids; genetic engineering; culture product |
| 01/29/2004 | US20040018542 Phosphodiesterase enzymes |
| 01/29/2004 | US20040018538 Mitochondrial dosimeter |
| 01/29/2004 | US20040018531 Methods of identifying and isolating stem cells and cancer stem cells |
| 01/29/2004 | US20040018226 Electroprocessing of materials useful in drug delivery and cell encapsulation |
| 01/29/2004 | US20040018205 Mutated immunogenic peptides derived from R9M, polynucleotides coding for same and therapeutic uses thereof |
| 01/29/2004 | US20040018204 Compositions and methods for WT1 specific immunotherapy |
| 01/29/2004 | US20040018196 Proteins and nucleic acids encoding same |
| 01/29/2004 | US20040018195 Antidiabetic complemetary determining region protein that binds epitopes containing specific amino acid sequences |
| 01/29/2004 | US20040018191 Neutralizing human anti-IGFR antibody |
| 01/29/2004 | US20040018189 Nucleic acid and corresponding protein entitled 121P2A3 useful in treatment and detection of cancer |
| 01/29/2004 | US20040018184 Administering mixtures of monocytes and drugs selected from taxanes, alkaloids, antibiotics or enzyme inhibitors, as anticarcinogenic agents |
| 01/29/2004 | US20040018183 Modified natural killer cell lines and methods of use |
| 01/29/2004 | US20040018182 Thymidine kinase expressing natural killer cell lines and methods of use |
| 01/29/2004 | US20040018178 Ablation of bone marrow and grafting genetic engineered isogeneic, allogeneic or xenogeneic cells, for prophylaxis of tumors or cancer |
| 01/29/2004 | US20040018177 Vacination method |
| 01/29/2004 | US20040018174 Cell therapy for regeneration |
| 01/29/2004 | US20040018149 Methods for cultivating dermal fibroblasts, methods for preparing in vitro dermis equivalents, methods for preparing three-dimensional in vitro skin equivalents, an in vitro dermis equivalent, a three dimensional in vitro skin |
| 01/29/2004 | CA2851035A1 Methods for using artificial polynucleotides and compositions thereof to reduce transgene silencing |
| 01/29/2004 | CA2531176A1 Sperm cell process system |
| 01/29/2004 | CA2493768A1 Embryonic stem cell markers and uses thereof |
| 01/29/2004 | CA2493679A1 Methods for generating enhanced antibody-producing cell lines with improved growth characteristics |
| 01/29/2004 | CA2493406A1 Gm-negative ehv-mutants without heterologous elements |
| 01/29/2004 | CA2492919A1 Use of specific myb genes for the production of transgenic plants tolerant to biotic and abiotic stresses |
| 01/29/2004 | CA2492905A1 Method of obtaining viable human liver cells, including hepatic stem/progenitor cells |
| 01/29/2004 | CA2492498A1 Flea and tick octopamine receptor nucleic acid molecules, proteins and uses thereof |
| 01/29/2004 | CA2467691A1 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 01/28/2004 | EP1384785A1 Method for producing transgenic plant using an auxin synthesis gene as a positive selectable marker gene |
| 01/28/2004 | EP1384775A1 Somatic pluripotent cells |
| 01/28/2004 | EP1384774A1 Glycosaminoglycan/collagen complexes and use thereof |
| 01/28/2004 | EP1384726A2 Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| 01/28/2004 | EP1384075A1 Methods of detecting early renal disease in animals |
| 01/28/2004 | EP1383931A1 Nucleic acid vaccines for prevention of flavivirus infection |
| 01/28/2004 | EP1383929A2 Genes expressed in intestinal epithelium and peyer's patch m cells |
| 01/28/2004 | EP1383927A2 New polynucleotides and polypeptides of the erythropoietin gene |
| 01/28/2004 | EP1383922A2 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer |
| 01/28/2004 | EP1383895A2 Polynucleotides and polypeptides of the ifnalpha-5 gene |
| 01/28/2004 | EP1383893A2 Proteins and nucleic acids encoding same |
| 01/28/2004 | EP1383892A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/28/2004 | EP1383890A2 Mutants of desoxycytidine kinase having extended enzymatic activity |
| 01/28/2004 | EP1383889A1 Modified organs and cells for xenotransplantation |
| 01/28/2004 | EP1383886A2 D-hydantoinase from ochrobactrum anthropi |
| 01/28/2004 | EP1383884A2 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon |
| 01/28/2004 | EP1383883A2 Asthma-associated snps around microsatellite marker d2s308 and identification of human prolyl-oligopeptidase-dpp10 |
| 01/28/2004 | EP1383876A1 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 01/28/2004 | EP1383874A1 Variants of lipoxygenase and their use |
| 01/28/2004 | EP1383872A2 Genetically modified yt cell line and use thereof |
| 01/28/2004 | EP1383869A1 Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom |
| 01/28/2004 | EP1383868A2 A method for the preparation of immunologically inert amniotic membranes |
| 01/28/2004 | EP1383867A2 Stem cell differentiation |
| 01/28/2004 | EP1383866A1 Culture system for mouse tracheal epithelial cells |